Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
Oct 5 (Reuters) — NeoGenomics, Inc.: Neogenomics Announces Executive Leadership And Board Of Directors Succession Plan Neogenomics, - Appoints Warren Stone As Ceo And Board Member Effective January 4, 2027 Neogenomics, - Tony Zook To Become Executive Chairman Effective January 4, 2027 Neogenomics, - Appoints Michael Ke
Tony Zook will transition from his role as CEO of NeoGenomics to become Executive Chairman.
Neogenomics appointed Warren Stone as Chief Executive Officer effective January 4, 2027. Tony Zook will transition to Executive Chairman on the same date. Lynn Tetrault will step down as Board Chair, and Michael Kelly becomes Lead Independent Director.
NeoGenomics announced a succession plan: Warren Stone will become CEO on Jan 4, 2027, with Tony Zook moving to Executive Chair. The company also expects preliminary Q3 revenue of $209 million and reiterated full-year guidance.